Genitourinary tumors

Xem 1-3 trên 3 kết quả Genitourinary tumors
  • For decades we have been learning about the interplay between tumors and the immune system. Our knowledge seemed somewhat incomplete and indirect, like listening to the ocean waves through a shell. Only recently, cancer immunotherapy has started to become a reality, with Provenge (Dendreon Corporation, WA), an autologous antigen-presenting cell preparation, earning the approval of United States Food and Drug Administration (FDA) for the treatment of advanced prostate cancer in 2010.

    pdf228p wawawawawa 27-07-2012 47 16   Download

  • Immune system is composed of innate and adaptive responses and plays critical roles in cancer development and destruction. A century ago, Paul Ehrlich postulated that cancer would be quite common in long-lived organisms if not for the protective effects of immunity. About 50 years later, Burnet and Thomas proposed the concept of cancer immunosurveillance based on the experimental evidence of immune recognition of tumor antigens expressed on tumor cells (Dunn et al. 2004 ) . In 1971, the US Congress created a National Cancer Act – a War on Cancer.

    pdf489p hotmoingay 04-01-2013 25 8   Download

  • Clinical Manifestations Patients with cancer who develop deep venous thrombosis usually develop swelling or pain in the leg, and physical examination reveals tenderness, warmth, and redness. Patients who present with pulmonary embolism develop dyspnea, chest pain, and syncope, and physical examination shows tachycardia, cyanosis, and hypotension. Some 5% of patients with no history of cancer who have a diagnosis of deep venous thrombosis or pulmonary embolism will have a diagnosis of cancer within 1 year.

    pdf5p thanhongan 07-12-2010 35 3   Download

CHỦ ĐỀ BẠN MUỐN TÌM

Đồng bộ tài khoản